Walgreens Boots Alliance Inc
NASDAQ:WBA
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
8.23
26.65
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one WBA stock under the Base Case scenario is 52.39 USD. Compared to the current market price of 8.66 USD, Walgreens Boots Alliance Inc is Undervalued by 83%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Walgreens Boots Alliance Inc
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for WBA cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Economic Moat
Walgreens Boots Alliance Inc
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Walgreens Boots Alliance Inc. stands as a pivotal player in the global healthcare landscape, emerging from the merger of Walgreens and Alliance Boots in 2014. With a vast network of over 9,000 retail pharmacy and health and wellness locations across the United States and nearly 2,500 stores in Europe, the company is strategically positioned to serve millions of customers. Beyond its extensive brick-and-mortar presence, Walgreens Boots Alliance is heavily invested in the growing trend of integrated healthcare solutions, offering services ranging from pharmacy distribution and clinical services to health and beauty products. The company aims to evolve into a comprehensive healthcare partner, e...
Walgreens Boots Alliance Inc. stands as a pivotal player in the global healthcare landscape, emerging from the merger of Walgreens and Alliance Boots in 2014. With a vast network of over 9,000 retail pharmacy and health and wellness locations across the United States and nearly 2,500 stores in Europe, the company is strategically positioned to serve millions of customers. Beyond its extensive brick-and-mortar presence, Walgreens Boots Alliance is heavily invested in the growing trend of integrated healthcare solutions, offering services ranging from pharmacy distribution and clinical services to health and beauty products. The company aims to evolve into a comprehensive healthcare partner, enhancing access to essential services while navigating the shifting dynamics of the retail and pharmacy sectors.
However, investors should be aware of the challenges that accompany Walgreens Boots Alliance’s ambitious growth strategy. The company has faced pressures from pricing competition, evolving regulatory environments, and increasing operating costs, particularly amid the COVID-19 pandemic. In response, Walgreens is optimizing its store footprint and enhancing its digital capabilities, which includes a robust online pharmacy presence. As the demand for accessible healthcare grows, especially in light of an aging population, Walgreens Boots Alliance remains focused on leveraging technology and partnerships to innovate its service offerings. For investors, this journey represents a blend of potential risks and strategic opportunities, making it essential to monitor the company’s adaptive strategies in the dynamic healthcare market closely.
Walgreens Boots Alliance, Inc. is a global leader in retail pharmacy and health and wellness, with a diverse range of business segments. Below are the core business segments of the company:
-
Retail Pharmacy USA:
- This segment primarily consists of Walgreens and Duane Reade stores across the United States. It involves the sale of prescription and over-the-counter medications, health and wellness products, personal care items, and photo services. The segment focuses on providing accessible healthcare services and enhancing customer experience through digital initiatives.
-
Pharmaceutical Wholesale:
- This segment operates through Alliance Healthcare, which provides distribution services to pharmacy customers, physician offices, and hospitals. It focuses on delivering pharmaceuticals and healthcare products, along with value-added services such as logistics and inventory management.
-
International Retail Pharmacy:
- This segment includes Boots UK and other retail pharmacy operations in several international markets, such as Europe, and other regions. It encompasses retail pharmacy services, health and beauty products, and cosmetic products. Boots also offers services such as health clinics and optometry services, integrating healthcare into the retail pharmacy experience.
-
Health and Wellness Services:
- Walgreens Boots Alliance emphasizes the integration of health and wellness services within its retail operations. This includes initiatives to provide comprehensive healthcare solutions, chronic disease management, vaccination services, and wellness programs aimed at improving community health outcomes.
-
Pharmacy and Healthcare Services:
- This segment also involves advanced pharmacy services, especially for health systems and insurers. They provide tailored medication management and pharmacy benefit solutions to optimize health outcomes and costs for patients and healthcare providers.
By leveraging its extensive network of retail locations and a comprehensive range of health services, Walgreens Boots Alliance aims to enhance healthcare accessibility and improve overall patient care, making it a key player in the global healthcare landscape.
Walgreens Boots Alliance Inc. (WBA) possesses several unique competitive advantages that differentiate it from its rivals in the pharmacy and retail health sector:
-
Extensive Retail Network: Walgreens has one of the largest retail pharmacy chains in the U.S., with thousands of locations. This extensive network provides ease of access for customers and a significant market presence that rivals may find difficult to match.
-
Diverse Service Offering: WBA operates in both the retail pharmacy and wholesale pharmaceutical distribution sectors, which diversifies its revenue streams. This includes not just prescription drugs but also over-the-counter medications, personal care products, and health and wellness services.
-
Strong Brand Recognition: Walgreens is a well-established brand with high customer loyalty. The company benefits from a long-standing reputation in the healthcare and pharmacy sectors, enhancing customer trust and repeat business.
-
Vertical Integration: WBA’s strategic integration of pharmacy operations with healthcare services positions it advantageously. By combining retail pharmacy with the wholesale business via Alliance Healthcare, they can achieve better pricing, optimize supply chains, and manage inventory efficiently.
-
Partnerships and Collaborations: The company has formed strategic partnerships with healthcare providers, insurers, and technology companies, enabling it to enhance patient care and health outcomes. Investments in telehealth and digital health initiatives further expand its service capabilities.
-
Pharmacy Benefit Management (PBM): Through its ownership of a PBM, WBA can influence drug pricing and enhance its negotiating power with pharmaceutical companies, thereby providing competitive pricing and better service for customers.
-
Focus on Health and Wellness: Walgreens is increasingly focusing on preventive care and health services, including immunizations and health screenings. This shift towards wellness creates additional revenue opportunities and strengthens customer relationships.
-
Technology Integration: Investments in digital platforms and technology, such as mobile apps for prescriptions and health records, enhance the customer experience and streamline operations. This technological adaptability gives them an edge over competitors relying on traditional models.
-
Global Reach: With operations in various international markets (primarily in Europe through Boots), WBA has a broader audience and market expansion opportunities, allowing for operational efficiency and shared best practices across regions.
-
Cost Leadership: Due to its scale, WBA can leverage its purchasing power to negotiate better terms with suppliers, passing some of the cost savings to customers or reinvesting for improved service offerings.
These competitive advantages empower Walgreens Boots Alliance to navigate the complex healthcare landscape effectively while maintaining a strong market presence against rivals.
Walgreens Boots Alliance Inc. (WBA) faces several risks and challenges that could impact its business in the near future:
-
Regulatory Changes: The healthcare and retail pharmacy sectors are heavily regulated. Any changes in healthcare policies or regulations, such as drug pricing reforms, could significantly affect WBA’s operational costs and profit margins.
-
Competition: The retail pharmacy landscape is becoming increasingly competitive, with the rise of online pharmacies, discount retailers, and grocery chains expanding their healthcare offerings. Increased competition may lead to price wars and reduced market share.
-
E-commerce Growth: The shift towards online shopping, particularly accelerated by the COVID-19 pandemic, poses a challenge for traditional brick-and-mortar retailers, including pharmacies. WBA needs to enhance its digital presence and capabilities to compete effectively.
-
Supply Chain Disruptions: Ongoing supply chain challenges can impact product availability, which may affect sales and customer satisfaction. Fluctuations in the supply of generic drugs, in particular, could pose a risk.
-
Health Trends and Demographics: Changing consumer preferences towards health and wellness can affect WBA’s traditional pharmaceutical business. Failing to adapt to these trends could limit opportunities for growth.
-
Litigation Risks: WBA, like many pharmacy chains, faces legal challenges related to opioid distribution and other liability claims. Ongoing litigation can result in significant financial liabilities or reputational damage.
-
Debt Levels: WBA carries a substantial amount of debt, which can limit financial flexibility and increase vulnerability to interest rate fluctuations. High debt levels could strain operations in a rising interest rate environment.
-
Technology and Cybersecurity Risks: As WBA invests in technology to enhance customer experience and efficiency, it faces risks related to cybersecurity threats that could compromise sensitive customer data and disrupt operations.
-
Economic Conditions: Economic downturns can affect consumer spending, particularly on non-essential health products and services. A recession could lead to reduced foot traffic in stores and lower overall sales.
-
International Markets: WBA operates in various global markets, exposing the company to foreign exchange risks, political instability, and varying healthcare regulations that could complicate international operations.
To successfully navigate these risks, Walgreens Boots Alliance will need to focus on strategic adaptability, technological advancement, and maintaining a strong financial position.
Revenue & Expenses Breakdown
Walgreens Boots Alliance Inc
Balance Sheet Decomposition
Walgreens Boots Alliance Inc
Current Assets | 18.3B |
Cash & Short-Term Investments | 3.1B |
Receivables | 5.9B |
Other Current Assets | 9.4B |
Non-Current Assets | 62.7B |
Long-Term Investments | 2.3B |
PP&E | 30.1B |
Intangibles | 28.5B |
Other Non-Current Assets | 1.8B |
Current Liabilities | 27B |
Accounts Payable | 14.1B |
Accrued Liabilities | 11B |
Other Current Liabilities | 1.9B |
Non-Current Liabilities | 43.6B |
Long-Term Debt | 9B |
Other Non-Current Liabilities | 34.7B |
Earnings Waterfall
Walgreens Boots Alliance Inc
Revenue
|
147.7B
USD
|
Cost of Revenue
|
-121.1B
USD
|
Gross Profit
|
26.5B
USD
|
Operating Expenses
|
-24B
USD
|
Operating Income
|
2.5B
USD
|
Other Expenses
|
-11.2B
USD
|
Net Income
|
-8.6B
USD
|
Free Cash Flow Analysis
Walgreens Boots Alliance Inc
USD | |
Free Cash Flow | USD |
Walgreens Boots Alliance faced significant financial challenges in fiscal 2024, with a GAAP net loss of $8.6 billion, primarily due to $2.3 billion in tax asset valuation charges. Despite a 28% decline in adjusted EPS to $2.88, pharmacy sales increased 11.7%, driven by brand inflation. The company aims to stabilize operations with a fiscal 2025 adjusted EPS guidance of $1.40 to $1.80, targeting $100 million in annual operating income (AOI) from a store closure program of 1,200 stores over three years. Plans include cutting costs by over $1 billion, reducing capital expenditures by $150 million, and bolstering cash flow through working capital initiatives.
What is Earnings Call?
WBA Profitability Score
Profitability Due Diligence
Walgreens Boots Alliance Inc's profitability score is 39/100. The higher the profitability score, the more profitable the company is.
Score
Walgreens Boots Alliance Inc's profitability score is 39/100. The higher the profitability score, the more profitable the company is.
WBA Solvency Score
Solvency Due Diligence
Walgreens Boots Alliance Inc's solvency score is 38/100. The higher the solvency score, the more solvent the company is.
Score
Walgreens Boots Alliance Inc's solvency score is 38/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
WBA Price Targets Summary
Walgreens Boots Alliance Inc
According to Wall Street analysts, the average 1-year price target for WBA is 10.2 USD with a low forecast of 7.07 USD and a high forecast of 14.7 USD.
Dividends
Current shareholder yield for WBA is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Ownership
WBA Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Walgreens Boots Alliance, Inc. engages in the provision of drug store services. The company is headquartered in Deerfield, Illinois and currently employs 202,000 full-time employees. The company went IPO on 2014-12-31. The firm operates through three segments: Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Retail Pharmacy USA segment consists of the Walgreen Co. (Walgreens) business, which includes the operation of retail drugstores, care clinics and providing specialty pharmacy services. The Retail Pharmacy International segment consists primarily of the pharmacy-led health and beauty retail businesses and optical practices. The Pharmaceutical Wholesale segment consists of equity method investment in AmerisourceBergen. The firm's portfolio of retail and business brands includes Walgreens, Duane Reade, Boots, as well as global health and beauty product brands, including No7, NICE!, Soap & Glory, Liz Earle, Finest Nutrition, Botanics, Well Beginnings, Sleek MakeUP and YourGoodSkin.
Contact
IPO
Employees
Officers
The intrinsic value of one WBA stock under the Base Case scenario is 52.39 USD.
Compared to the current market price of 8.66 USD, Walgreens Boots Alliance Inc is Undervalued by 83%.